IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model.
Saved in:
| Title: | IKK2 controls the inflammatory potential of tissue-resident regulatory T cells in a murine gain of function model. |
|---|---|
| Authors: | Cardinez C; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Hao Y; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK., Kwong K; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK., Davies AR; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Downes MB; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Roberts NA; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Price JD; Division of Genome Sciences and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Hernandez RA; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Lovell J; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Chand R; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Feng ZP; ANU Bioinformatics Consultancy, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Enders A; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Vinuesa CG; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Francis Crick Institute, London, UK., Miraghazadeh B; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia., Cook MC; Centre for Personalised Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Translational Research Unit, The Canberra Hospital, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia. mc2386@cam.ac.uk.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK. mc2386@cam.ac.uk. |
| Source: | Nature communications [Nat Commun] 2024 Mar 25; Vol. 15 (1), pp. 2345. Date of Electronic Publication: 2024 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
